Ahmet Güner1, Ömer Çelik1, Ahmet Arif Yalçın1, Murat Örten2, Serkan Kahraman1, Macit Kalçık3, Ezgi Gültekin Güner1, Çağdaş Topel4, Mehmet Ertürk1

1Clinic of Cardiology, İstanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital University of Health Sciences, İstanbul, Turkey
2Clinic of Neurology, İstanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, İstanbul, Turkey
3Department of Cardiology, Hitit University Faculty of Medicine, Çorum, Turkey
4Clinic of Radiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey

Keywords: Stroke; magnetic resonance imaging; carotid artery; stent endovascular


Introduction: Cerebral embolism after carotid artery stenting (CAS) remains a matter of concern in frailty patients. The prognostic nutrition index (PNI), which provides an objective assessment of nutritional status, is a useful prognostic indicator in cardiovascular diseases. We aim to determine the value of pre-procedural PNI in predicting cerebral embolism including stroke, transient ischemic attack (TIA), and silent new ischemic cerebral lesions (SNICLs).

Patients and Methods: We retrospectively evaluated 138 patients (mean age= 70.6 ± 6.7 years, male= 99) who underwent CAS. Inclusion criteria were as follows: i) availability of all medical records including albumin value and lymphocyte count, ii) having cranial imaging after CAS, iii) having symptomatic carotid stenosis 50-99% or asymptomatic carotid stenosis ≥60-99%. The study population was divided into two subgroups according to the presence of cerebral embolism as cerebral embolism (+) cerebral embolism (-) groups.

Results: Among the study population, 22 patients (16%) had at least 1 SNICL, seven patients (5.0%) had an ischemic stroke, and five patients (3.6%) had TIA. The cerebral embolism (+) group had a significantly lower PNI, older age, more frequent history of stroke, a higher proportion of type III aortic arch, and longer fluoroscopy time than the cerebral embolism (-) group. Low PNI was identified as one of the independent predictors of cerebral embolism (OR= 0.808; 95% CI= 0.670-0.975; p= 0.026), and PNI lower than 44.7 predicted cerebral embolism with a sensitivity of 70.6% and a specificity of 61.1% (AUC= 0.739; 95% CI= 0.651 to 0.827; p< 0.001).

Conclusion: The current data suggest that PNI is an independent prognostic factor for cerebral embolic complications after CAS procedures.


Carotid artery stenting (CAS) is increasingly being used in recent times for endovascular treatment as a less invasive alternative to carotid endarterectomy (CEA)(1,2). Technical advances such as proximal balloon occlusion and the availability of filter devices have reduced cerebral embolic complications; therefore, CAS is considered a more viable therapeutic option(3). Based on clinical research, the outcomes of CAS performed by experienced surgeons, particularly with the use of embolic protection devices, are similar to those of CEA, although CAS was shown to be associated with a higher incidence of postoperative cerebral embolism(3-5). Therefore, the high risk of cerebral ischemic complications, including silent new ischemic cerebral lesions (SNICL), stroke, and transient ischemic attacks (TIA) is a known limitation of CAS(6). Some recent studies have focused on the risk factors associated with post-CAS SNICL, although the results are inconsistent(6-8). CAS outcomes can only be improved by minimizing postoperative ischemic events.

The Prognostic Nutrition Index (PNI) is a scoring system that indicates the nutritional status and serves as a determinant of morbidity and mortality in patients with cardiovascular diseases(9-12). However, limited data are available regarding its role in carotid artery disease or its association with ischemic complications, such as SNICL(9-11). In this study, we investigated the role of preoperative PNI as a predictor of post-CAS cerebral ischemic complications.

Materials and Methods

Study Design and Patient Selection

This retrospective study included 138 patients who underwent CAS for carotid artery revascularization at our tertiary center between January 2017 and April 2021. Following were the inclusion criteria for this study: availability of medical records showing serum albumin and lymphocyte levels, availability of cranial imaging performed 48 hours after CAS, and symptomatic internal carotid artery (ICA) stenosis (50-99%) or asymptomatic ICA stenosis ≥60-99% based on computed tomographic angiography (CTA) or digital subtraction angiography (DSA) findings. Following were the exclusion criteria: intracranial bleeding, intracranial arteriovenous malformation or aneurysm, total occlusion of the carotid artery, uncontrolled diabetes mellitus, a history of coagulation disorders, intolerance or allergies to antiplatelet therapy, malignancy, CAS secondary to vasculitis, active infection, recent major surgery, a history of systemic inflammatory disease, or end-stage renal disease necessitating renal replacement therapy, or unavailability of records showing preoperative serum albumin or lymphocyte levels. Demographic data, physical examination findings, laboratory test findings, and operative data were obtained from the hospital’s electronic database. Grading and evaluation of carotid stenosis were performed based on guidelines in the literature(13). TIA was defined as a brief episode of neurological dysfunction due to focal cerebral ischemia without permanent cerebral infarction(14). Ischemic stroke was defined as an episode of neurological dysfunction due to focal cerebral, spinal, or retinal infarction(15,16). An experienced neurologist performed detailed neurological evaluation 48 hours before and after the operation in patients with suspected neurological disorders. Patients with a history of TIA, retinal ischemic event, or ischemic stroke within the last six months were considered symptomatic(14-16). Morphological evaluation of the degree of stenosis was performed using CTA of the supra-aortic trunk together with Doppler ultrasonography. All patients underwent pre-procedure evaluation for malnutrition using the PNI. The PNI was calculated using the following formula: 10x serum albumin (g/dL)+ (0.005xlymphocytes/μL)(12). The study was performed in accordance with the principles of the Declaration of Helsinki and was approved by the local Institutional Review Board (Ethics Committee approval number 2021/11).

Endovascular Treatment of Carotid Artery Stenosis

All procedures were performed by two invasive cardiologists with greater than 10 years’ experience in carotid stenting. All risks were explained in detail to all patients, and written informed consent was obtained prior to the procedure. Medical treatment (acetylsalicylic acid 100 mg/day+clopidogrel 75 mg/ day) was initiated in all patients at least five days preoperatively. All carotid endovascular interventions were performed via the percutaneous transfemoral route under local anesthesia (conscious sedation was used as deemed appropriate by the surgeon). Electrocardiography, oxygen saturation and blood pressure monitoring were performed in all patients throughout all procedures. Diagnostic angiography was performed, and unfractionated heparin (100 units/kg) was administered at the commencement of the procedure. The procedure was initiated using a femoral 8-French sheath, and stent diameters were determined following bilateral carotid artery angiography and cerebral DSA. An embolic protection device (EmboShield®, Abbott Vascular, IL, USA) was placed in the distal extracranial carotid artery. The stent (Xact®, Abbott Vascular, IL, USA) was advanced through the guide catheter. Balloons were used either before or after stent dilation, at the discretion of the cardiologist. Intravenous atropine (1 mg) was prophylactically administered to patients in whom the heart rate reduced to <60 beats/ min after carotid ballooning or after stenting in patients with heart rate <60 beats/min before CAS and in those with heart rate >60 beats/min. Atropine administration was ineffective against hypotension immediately after CAS in a few patients; the blood pressure returned to normotensive values after rapid intravenous infusion of physiological saline solution. Finally, angiography was performed to evaluate vascular structures associated with CAS.

Post-Procedure Follow-Up

All patients were transferred to the coronary intensive care unit after CAS and underwent clinical, neurological, and hemodynamic follow-up during the first 24 hours postoperatively. Patients with hypotension continued to receive intravenous physiological saline solution and positive inotropic agent infusions, if indicated. Antihypertensive therapy was discontinued during intensive care follow-up. Cranial imaging was performed over 48 hours after CAS even in asymptomatic patients for evaluation of possible cerebral microembolism.

Clinical and Neurological Imaging for Evaluation of Cerebral Embolism

Magnetic resonance imaging (MRI) with or without CTA was performed for the evaluation of cerebral embolic events. In addition to the delineation of the vascular structure, CTA demonstrated the detailed anatomical orientation of the vessel with regard to the brain parenchyma and bone tissue and clearly showed intravascular pathologies, if any. CT findings of early ischemic changes included a hyperdense artery, loss of graywhite matter separation, insular stripe, and lentiform nucleus effacement(14-16). MRI findings of early cerebral infarction included the absence of normal blood flow, arterial enhancement, gyral edema on T1-weighted imaging, sulcal effacement, and loss of gray-white matter separation(5,16). Some patients underwent brain MRI [diffusion-weighted imaging (DWI)] 48 hours pre- and postoperatively. MRI was performed using a 16-channel head coil, and data were recorded using a 1.5 T scanner (Aera®, Siemens Medical Systems, Enlargen, Germany). DWI was performed using echo-planar imaging in the axial plane at 6000/89 ms repetition time/echo time, 1736 kHz bandwidth, 4-mm slice thickness, and 0 and 1000 mm2 /s b-values. Pre- and postoperative DWI findings were interpreted by a single radiologist with greater than six years of experience in neuroradiology. The radiologist was blinded to patients’ clinical and operative data. Perioperative neurological status was evaluated by an experienced neurologist with greater than 10 years of experience. SNICL was defined as a new hyperintensity observed on postoperative DWI compatible with signal loss on an apparent diffusion coefficient map on the ipsilateral side.

SNICL also included ischemic lesions and the absence of neurological symptoms associated with ischemia. The following scales were considered for neurological evaluation by an experienced neurologist: a detailed history was obtained regarding any loss/impairment of consciousness, signs of lateralization, speech disorder, headache, or combinations of these features. The patients’ level of consciousness was evaluated before the intervention. Dysarthria detected during the neurological examination was defined as a speech disorder, and aphasia was considered a sign of lateralization. We also recorded findings of facial paralysis (central), hemiparesis, and evidence of possible pyramidal involvement.

Study Endpoint

The primary endpoint was cerebral embolism including SNICLs that developed within 48 hours after CAS.

Statistical Analysis

All statistical analyses were performed using the SPSS software, version 24.0 (SPSS Inc., Chicago, IL, USA). Pre-procedural parameters, procedural data, and post-procedural outcomes were compared between patients with and without cerebral embolism. The normal distribution hypothesis was tested using graphical (histograms, probability curves) and numerical methods (Kolmogorov-Smirnov and Shapiro-Wilk tests). Normally distributed continuous variables are expressed as mean ± standard deviation and non-normally distributed continuous variables as median values (25th-75th percentiles) and were compared using the student-t or Mann-Whitney U test. Categorical variables are presented as frequencies and percentages, and differences between proportions were calculated using the Chi-square or Fisher exact test. Correlational analyses were performed using the Pearson or Spearman’s correlation tests. Variables that showed a p-value of <0.05 on univariable analysis were subjected to multivariable logistic regression analysis to determine independent predictors of cerebral embolism. We used 95% confidence intervals (CI) to estimate the precision of the odds ratio (OR) in each model. Cut-off values for regression variables were calculated using receiver operating characteristic (ROC) analysis. All tests were two-tailed, and p<0.05 was considered statistically significant.


The study included 138 patients (mean age 70.6 ± 6.7 years, 99 men). In the study group, 24 patients (17.4%) showed at least one new hyperintense lesion on DWI, seven patients (5.0%) had an ischemic stroke, and five patients (3.6%) experienced a TIA. The SNICL number was between 1 and 15, with lesion diameter varying from 2 to 8 mm.

Based on the occurrence of cerebral embolism, the study group was subcategorized into the cerebral embolism-positive and cerebral embolism-negative groups. Table 1 summarizes the intergroup comparison of baseline demographic and clinical characteristics of patients. No intergroup difference was observed in sex, hypertension, coronary artery disease, congestive heart failure, diabetes mellitus, pre-procedural symptoms, and contralateral carotid artery stenosis. Patients in the cerebral embolism-positive group were significantly older than those in the cerebral embolism-negative group (Figure 1A), with a greater prevalence of stroke history. The prevalence of type III aortic arch was significantly higher in the cerebral embolismpositive than in the cerebral embolism-negative group (33.3 vs. 7.8%, p= 0.001). The overall fluoroscopy time was significantly longer in the cerebral embolism-positive than in the cerebral embolism-negative group (21.6 ± 11.5 vs. 16.4 ± 8.4 min, p= 0.001) (Figure 1B). No intergroup difference was observed in the length or degree of carotid artery stenosis. No intergroup differences were observed in the incidence of pre-dilatation, post-dilatation, and degree of residual stenosis (Table 1). The common carotid artery-ICA angle (41.2 ± 10.7 vs. 29.8 ± 9.6º, p<0.001) (Figure 1C), proximal tortuosity index (138.2 ± 17.1 vs. 99.6 ± 35.4, p< 0.001), and distal tortuosity index (161.7 ± 25.5 vs. 120.2 ± 36.2, p< 0.001) were significantly greater in the cerebral embolism-positive than in the cerebral embolism-negative group (Table 1). PNI was significantly lower in the cerebral embolism-positive than in the cerebral embolismnegative group (42.4 ± 4.9 vs. 47.2 ± 5.7, p< 0.001) (Table 1).

Variables that showed a p-value of <0.05 on univariate analysis were subjected to multiple logistic regression analysis to determine the independent predictors of cerebral embolism. Old age (OR= 1.294, 95% CI= 1.083-1.546, p= 0.004), type III aortic arch (OR= 1.096, 95% CI= 1.035–2.478, p= 0.036), lengthy fluoroscopy time (OR= 1.068, 95% CI= 1.031-1.378, p= 0.022), and low PNI (OR= 0.808, 95% CI= 0.670-0.975, p= 0.026) were shown to be independent predictors of cerebral embolism (Table 2).

Based on ROC curve analysis, age >73.5 years predicted cerebral embolism with sensitivity of 83.3% and specificity of 75.5% [area under the curve (AUC)= 0.895, 95% CI= 0.840- 0.950, p< 0.001], fluoroscopy time >14.9 min predicted cerebral embolism with sensitivity of 58.1% and specificity of 56.1% (AUC= 0.625, 95% CI= 0.497-0.752, p= 0.041), and PNI< 44.7 predicted cerebral embolism with sensitivity of 70.6% and specificity of 61.1% (AUC= 0.739, 95% CI= 0.651- 0.827, p< 0.001) (Figure 2).

The study population was categorized into the following groups based on the PNI cut-off value (44.7) determined by ROC curve analysis: patients with PNI< 44.7 (low-PNI group) and those with PNI≥ 44.7 (high-PNI group). Table 3 shows a comparison of the demographic, clinical, and angiographic characteristics of patients with low and high PNI. Cerebral embolism was significantly more common in the high-PNI than in the low-PNI group (42.3 vs. 16.3%, p= 0.001). Moreover, the prevalence of stroke history (p= 0.015) was significantly higher and total fluoroscopy time was significantly longer (p= 0.034) in the high-PNI than in the low-PNI group (Table 3). PNI and age (r= -0.246, p= 0.004) showed a statistically significant but weak negative correlation, whereas total fluoroscopy time and age (r= 0.295, p= 0.002) showed a statistically significant but weak positive correlation (Figure 3).


The major findings of the current study include: (i) Low PNI was significantly associated with cerebral embolism. (ii) Type III aortic arch, old age, lengthy fluoroscopy time, and low PNI were independent predictors of cerebral embolism on multivariate analysis.

Improved availability and accessibility of healthcare have led to increased life expectancy in an aging population; therefore, the prevalence of frailty has increased(17). Advanced age serves as a risk factor for cerebral embolic complications(2,6). Geriatric patients show significantly higher in-hospital postCAS major cerebral embolic complications, such as stroke or mortality(1,6,18). In this study, we observed a significant correlation between advanced age and cerebral embolic events (for example, TIA or stroke), which concurs with the findings reported in the literature(6,7,9,18). Frailty and carotid artery disease share some pathophysiological mechanisms, including malnutrition, bleeding, and thrombotic risk, all of which worsen the clinical outcomes in this patient population. Frailty refers to age-induced vulnerability to disease and is a useful predictor of perioperative outcomes(19,20). CAS is indicated as a minimally invasive approach in patients in whom CEA is considered a high-risk procedure. Reportedly, frailty measured by the five-factor modified frailty index serves as an independent predictor of perioperative stroke and mortality in patients who undergo CAS(19). Malnutrition, an indicator of morbidity and mortality in many cardiovascular diseases, is significantly associated with frailty and is widely prevalent in the geriatric population(21-24). PNI was used to assess perioperative nutritional status and predicted surgical morbidity and mortality in patients who underwent gastrointestinal surgery(12). Reportedly, PNI also predicts mortality in infectious and inflammatory heart disease(10,11,22). Caliskan et al. have recently indicated that the decreased PNI (<53.8) independently predicts impairment of coronary flow reserve in patients with inflammatory bowel disease(23). Recent research has confirmed an association between PNI and mortality in atherosclerotic cardiovascular diseases that require revascularization, as well as in pulmonary embolism(24-26). Previously, Peng et al. reported that chronic kidney disease patients with low PNI had a significant increase risk of cardiovascular disease and allcause mortality (HR= 3.07, 95% CI= 1.51-6.25 and HR= 2.18, 95% CI= 1.28-3.72, respectively)(27). Another study by Dong et al. reported a negative linear relationship between PNI score and contrast-associated acute kidney injury in patients undergoing coronary angiography complicated with coronary artery disease(28). In 2019, Teker et al. demonstrated that there was statistical significance between malnutrition (low PNI) and renal complications, hemorrhage, and mortality after coronary artery bypass graft surgery(29). Another interesting study by Tai et al. reported that PNI could be a candidate adjunctive predictor of coronary artery aneurysms in patients with Kawasaki disease(30). Several studies have investigated the prognostic role of certain biochemical and hematological parameters in patients who undergo CAS(9,31,32). Öcal et al. suggested that PNI may be a novel prognostic biomarker for CAS(9). However, our literature search did not yield any studies reporting the role of PNI as a predictor of cerebral embolism in elderly patients.

Complex vascular anatomy, including aortic arch type, is known to increase the risk of neurological complications(6,7,33) and contributes to the technical difficulty associated with carotid artery cannulation(34). However, recent research has shown no correlation between the aortic arch type and cerebral embolism(7). We recently observed that large ICA and external carotid artery angles predicted SNICL in CAS(6). However, in the current study, contrary to the findings reported in the literature, we did not observe this association with regard to the prediction of cerebral embolism(6). The disparity between our findings and those reported in the literature may be attributable to the retro spective design of this study, the inclusion of all cerebral embolic events, and the exclusion of cases in which data regarding preoperative serum albumin and lymphocyte levels were unavailable. Notably, Faggioli et al. reported a significant association between proximal and distal carotid tortuosity and the risk of post-CAS ischemic stroke(35). However, in this study, we observed no correlation between proximal and distal carotid tortuosity and cerebral embolism, including ischemic stroke.

Some studies have reported an association between perioperative data (for example, lesion characteristics, fluoroscopy time, and filter devices, among other variables) and in-hospital adverse events (stroke, TIA, or mortality). Lengthy operation time is a known risk factor for embolic events(6,36,37). Despite the positive correlation reported between stroke or TIA and the degree of stenosis and lesion length(36), we observed no such correlation in this study. Cerebral protection using filter devices significantly decreases the risk of post-CAS cerebral embolism(37,38), although studies have shown a high incidence of post-CAS cerebral microembolism. The use of distal protection filters during CAS in this study was associated with the following disadvantages: (a) The balloon needs to be expanded before passing the lesion and somewhere before filter insertion, which may lead to cerebral embolism. (b) Filters are unable to capture residues with diameters that are smaller than the pore diameter. (c) Inappropriate filter placement may cause passage of particles between the filter and the vascular structure, which can predispose to SNICLs, which may even be asymptomatic. However, proximal balloon occlusion systems, which are placed before any device passes the lesion, differ from distal protection filters and are more convenient for the surgeon.

Some patients present with hyperintense lesions on DWI, without any accompanying neurological symptoms; studies are being performed to investigate these intriguing findings. Although the clinical significance of subclinical embolic events remains unclear, some researchers suggest that silent ischemia may be closely associated with increased neurocognitive dysfunction(39). As these lesions can be better explained, it will be important to develop a system of preoperative risk classification to prevent or minimize silent embolic complications.

Study Limitations

Following are the limitations of this study: (i) the singlecenter retrospective design, the small sample size (n= 36), the use of only distal protection filters, and the unavailability of data regarding carotid plaque morphology are drawbacks of this study. (ii) Platelet inhibition and function were not evaluated in patients who underwent stent implantation. (iii) We did not measure levels of hormones that may affect PNI values.


PNI was an independent prognostic factor for post-CAS cerebral embolic complications. Immune nutritional status may play a key role in post-CAS prognosis. Therefore, low PNI serves as a significant risk factor for in-hospital cerebral embolism, including SNICL in patients who undergo CAS.

Ethics Committee Approval

The approval for this study was obtained from İstanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital Clinical Research Ethics Committee (Decision no: 2021/11, Date: 23.02.2021).

Peer Review

Externally peer-reviewed.

Author Contributions

Concept/Design - AG; Analysis/Interpretation - AG, EGG, MÖ, CA, MK; Data Collection - All of authors; Writing - AG; Critical Revision - ME; Final Approval - AG; Statistical Analysis - AG, MK; Overall Responsibility - AG, FU, AKK, SK, ÖÇ, ME.

Conflict of Interest

The authors declared that there was no conflict of interest during the preparation and publication of this article.

Financial Disclosure

The authors declared that this study has received no financial support.


  1. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/ SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. Catheter Cardiovasc Interv 2013;81:E76-123.
  2. Karaduman BD, Ayhan H, Keleş T, Bozkurt E. Efficacy and safety of carotid artery stenting: Experience of a single center Turk Kardiyol Dern Ars 2020;48:646-55.
  3. Müller MD, Lyrer PA, Brown MM, Bonati LH. Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis. Stroke 2021;52:e3-e5.
  4. Rosenfield K, Matsumura JS, Chaturvedi S, Riles T, Ansel GM, Metzge DG, et al. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med 2016;374:1011-20. [Crossref]
  5. Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med 2008;358:1572-9. [Crossref]
  6. Güner A, Çelik Ö, Topel Ç, Arif Yalçın A, Kalçık M, Uzun F, et al. The effect of complex vascular anatomy on silent new ischemic cerebral lesions in carotid artery stenting procedures (from the COMPLEX-CAS Trial). Vascular 2021:17085381211010016. [Crossref]
  7. Xu X, Feng Y, Bai X, Ma Y, Wang Y, Chen Y, et al. Risk factors for silent new ischemic cerebral lesions following carotid artery stenting. Neuroradiology 2020;62:1177-84. [Crossref]
  8. Bendszus M, Stoll G. Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol 2006;5:364-72. [Crossref]
  9. Öcal L, Küp A, Keskin M, Cerşit S, Çelik M, Eren H, et al. Prognostic significance of pre-procedural prognostic nutritional index in patients with carotid artery stenting. J Stroke Cerebrovasc Dis 2020;29:104932. [Crossref]
  10. Kahraman S, Zencirkıran Aguş H, Kalkan AK, Uzun F, Ertürk M, Kalkan ME, et al. Prognostic nutritional index predicts mortality in infective endocarditis. Turk Kardiyol Dern Ars 2020;48:392-402. [Crossref]
  11. Kurmus O, Aslan T, Eren M, Akbuga K, Erkan AF, Ekici B, et al. Nutritional status and severity of coronary artery disease. Coron Artery Dis 2021. [Crossref]
  12. Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index in gastrointestinal surgery. Am J Surg 1980;139:160-7. [Crossref]
  13. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339:1415-25. [Crossref]
  14. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et al. American Heart Association; American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Interdisciplinary Council on Peripheral Vascular Disease. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009;40:2276-93. [Crossref]
  15. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Buddy Connors JB, Culebras A, et al. American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Council on Nutrition, Physical Activity and Metabolism. An updated definition of stroke for the 21st century: a statement for healthcare professionals fromthe American Heart Association/ American Stroke Association. Stroke 2013;44:2064-89. [Crossref]
  16. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2018;49:e46-e110. [Crossref]
  17. Giallauria F, Di Lorenzo A, Venturini E, Pacileo M, D’Andrea A, Garofalo U, et al. Frailty in acute and chronic coronary syndrome patients entering cardiac rehabilitation. J Clin Med 2021;10:1696. [Crossref]
  18. Zahn R, Ischinger T, Hochadel M, Zeymer U, Schmalz W, Treese N, et al. Carotid artery stenting in octogenarians: results fromthe ALKK Carotid Artery Stent (CAS) Registry. Eur Heart J 2007;28:370-5. [Crossref]
  19. Faateh M, Kuo PL, Dakour-Aridi H, Aurshina A, Locham S, Malas M. Frailty as a predictor of outcomes for patients undergoing carotid artery stenting. J Vasc Surg. 2021;S0741-5214(21):00618-2. [Crossref]
  20. Mandelbaum AD, Hadaya J, Ulloa JG, Patel R, McCallum JC, De Virgilio C, et al. Impact of frailty on clinical outcomes after carotid artery revascularization. Ann Vasc Surg 2021;S0890-5096(21)00099-6. [Crossref]
  21. Gürbak İ, Güner A, Güler A, Şahin AA, Çelik Ö, Uzun F, et al. Prognostic influence of objective nutritional indexes on mortality after surgical aortic valve replacement in elderly patients with severe aortic stenosis (from the nutrition-SAVR trial). J Card Surg 2021;36:1872-81. [Crossref]
  22. Candeloro M, Di Nisio M, Balducci M, Genova S, Valeriani E, Pierdomenico SD, et al. Prognostic nutritional index in elderly patients hospitalized for acute heart failure. ESC Heart Fail 2020;7:2479-84. [Crossref]
  23. Caliskan Z, Tatlisu MA, Kahraman R, Gokturk S, Sayar S, Kostek O, et al. The impact of prognostic nutritional index on coronary flow reserve in patients with inflammatory bowel disease. Medeni Med J 2019;34:271-7. [Crossref]
  24. Keskin M, Hayıroglu MI, Keskin T, Kaya A, Tatlısu MA, Altay Servet, et al. A novel and useful predictive indicator of prognosis in ST-segment elevation myocardial infarction, the prognostic nutritional index. Nutr Metabol Cardiovasc Dis 2017;27:438-46. [Crossref]
  25. Keskin M, Ipek G, Aldag M, Altay S, Hayıroğlu Mİ, Börklü EB, et al. Effect of nutritional status on mortality in a patient undergoing coronary artery bypass grafting. Nutrition 2018;48:82-6. [Crossref]
  26. Hayiroglu MI, Keskin M, Keskin T, Uzun AO, Altay S, Kaya A, et al. A novel independent survival predictor in pulmonary embolism: prognostic nutritional index. Clin Appl Thromb Hemost 2018;24:633-9. [Crossref]
  27. Peng F, Chen W, Zhou W, Li P, Niu H, Chen Y, et al. Low prognostic nutritional index associated with cardiovascular disease mortality in incident peritoneal dialysis patients. Int Urol Nephrol 2017;49:1095-101. [Crossref]
  28. Dong X, Wang B, Chen S, Liu J, Xia Y, Wang S, et al. Association between prognostic nutritional index and contrast-associated acute kidney injury in patients complicated with chronic kidney disease and coronary artery disease. J Interv Cardiol 2021;2021:2274430. [Crossref]
  29. Teker Açıkel ME, Korkut AK. Impact of Controlling Nutritional Status Score (CONUT) and Prognostic Nutritional Index (PIN) on patients undergoing coronary artery bypass graft surgery. Heart Surg Forum 2019;22: E294-E297. [Crossref]
  30. Tai IH, Wu PL, Guo MM, Lee J, Chu CH, Hsieh KS, et al. Prognostic nutrition index as a predictor of coronary artery aneurysm in Kawasaki Disease. BMC Pediatr 2020;20:203. [Crossref]
  31. Shen H, Dai Z, Wang M. Preprocedural neutrophil to albumin ratio predicts in-stent restenosis following carotid angioplasty and stenting. J Stroke Cerebrovasc Dis 2019;28:2442-7. [Crossref]
  32. Stone PA, Thompson SN, Khan M, Northfield E, Schillinger R, Skaff P. The impact of biochemical markers on major adverse cardiovascular events and contralateral carotid artery stenosis progression following carotid interventions. Ann Vasc Surg 2017;38:144-50. [Crossref]
  33. Conway AM, Nguyen Tran NT, Qato K, Ehidom C, Stoffels GJ, Giongola G, et al. Complexity of aortic arch anatomy affects the outcomes of transcarotid artery revascularization versus transfemoral carotid artery stenting.Ann Vasc Surg 2020;67:78-89. [Crossref]
  34. Huibers A, Calvet D, Kennedy F, Czuriga-Kovács KR, Featherstone RL, Moll FL, et al. Mechanism of procedural stroke following carotid endarterectomy or carotid artery stenting within the International Carotid Stenting Study (ICSS) randomised trial. Eur J Vasc Endovasc Surg 2015;50:281-8. [Crossref]
  35. Faggioli G, Ferri M, Gargiulo M, Freyrie A, Fratesi F, Manzoli L, et al. Measurement and impact of proximal and distal tortuosity in carotid stenting procedures. J Vasc Surg 2007;46:1119-24. [Crossref]
  36. Naggara O, Touzé E, Beyssen B, Trinquart L, Chatellier G, Meder JF, et al. Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting: results from the endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review. Stroke 2011;42:380-8. [Crossref]
  37. Bijuklic K, Wandler A, Hazizi F, Schofer J. The PROFI Study (prevention of cerebral embolization by proximal balloon occlusion compared to filter protection during carotid artery stenting): a prospective randomized trial. J Am Coll Cardiol 2012;59:1383-9. [Crossref]
  38. Akkaya E, Vuruskan E, Gul ZB, Yildirim A, Pusuroglu H, Surgit O, et al. Cerebral microemboli and neurocognitive change after carotid artery stenting with different embolic protection devices. Int J Cardiol 2014;176:478-83. [Crossref]
  39. Hitchner E, Baughman BD, Soman S, Long B, Rosen A, Zhou W. Microembolization is associated with transient cognitive decline in patients undergoing carotid interventions. J Vasc Surg 2016;64:1719-25. [Crossref]

Figure and Tables